drugset / Trial / NCT00539656
Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers
Phase 1/2
Terminated
3 enrolled
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Cancer Foundation · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is to evaluate the safety of transplantation of two cord blood products, including toxicities in patients following high-dose, myeloablative chemotherapy for blood malignancies. It is also to determine if the use of two cord products results in an improvement in neutrophil engraftment.
Timeline
- Start
- 2007-12-20
- Primary completion
- 2009-10-20
- Completion
- 2009-10-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cord blood stem cells | Cell therapy | — | — |